Jamie Oliva, PhD, MS, RN, ANP-BC
  • Phone: (585) 275-1933
  • Office: HWH 4W208
  • Email: Jamie Oliva

Jamie Oliva, PhD, MS, RN, ANP-BC

  • Associate Professor Clinical Nursing

Education

  • PhD in Health Practice Research, 2016. University of Rochester. Rochester, NY
  • Genetics Fellowship (SGI), 2008. National Institute of Nursing Research, National Institutes of Health MD
  • Master of Science in Adult Nurse Practitioner, 1998. University of Rochester. Rochester, NY
  • Bachelor of Science,summa cum laude in Nursing, 1991. State University of NY College at Brockport. Brockport, NY

Associate Professor of Clinical Nursing, University of Rochester (Research & Education), Rochester, NY, US. 10/2022 - Current

Nurse Scientist, Wilmot Cancer Institute, University of Rochester (Research), Rochester, NY, US. 2016 - Current

Nurse Practitioner, Wilmot Cancer Institute, University of Rochester (Blood and Marrow Transplantation), Rochester, NY, US. 1998 - Current

Assistant Professor of Clinical Nursing, University of Rochester (Research & Education), Rochester, NY, US. 6/2016 - 10/2022
House of Delegates, Epsilon Xi Chapter Representative
Sigma Theta Tau, 2021
Use of a Mobile Phone Application for Chronic Graft-Versus-Host Disease Symptom Tracking and is Effects on Symptom Reporting and Disease Severity
3rd Annual WNY Finger Lakes Region Oncology Nursing Research Day, Wilmot Cancer Institute & Roswell Park Memorial Hospital, 2023
Buffalo, New York

Cancer in Primary Care
Advanced Practice Adult Gerontology Primary Care and Family Nurse Practitioner Program Guest Lecture Series, University of Rochester, 2023
Rochester, New York

Hematologic Malignancies
Advanced Practice Pediatric Nurse Practitioner Program Guest Lecture Series, UR School of Nursing, 2022
Rochester, New York

Some Simple Ways to Turn Your Clinical Question into a Workable Project
Kelly Clark BS, RN
WCI Nursing Research Conference, Wilmot Cancer Institute, 2021
Rochester, New York

Some Simple Ways to Turn Your Clinical Question into a Workable Project
Kelly Clark BS, RN
WCI Nursing Research Conference (enduring Oct 2021 to Jan 2022, via MyPath), Wilmot Cancer Institute, 2021
Rochester, New York

Heritable Hematologic Malignancies
Advanced Practice Pediatric Nurse Practitioner Program Guest Lecture Series, UR School of Nursing, 2021
Rochester, New York

Cancer in Primary Care
none
Advanced Practice Adult Gerontology Primary Care and Family Nurse Practitioner Program Guest Lecture Series, University of Rochester, 2021
Rochester, New York

Managing the Care of the Research Participant Workshop Co-coordinator December 2019
Kelly Clark BS, RN & Jamie Littleton MS, RN
Oncology Nursing Research Committee Workshop Series, Wilmot Cancer Institute, 2019
Rochester, New York
Palermo, B. & Oliva, J. L. (2023). Chapter 9: Evidence-based standards of hematology & oncology practice.. Textbook for the adultgerontology acute care nurse practitioner: Evidence-based standards of practice. (1st ed.).

Andolina, J. R., Walia, R., Oliva, J., Baran, J., Liesveld, J., Becker, M. W., Busacco, A., & Coppage, M. (2020). Non-donor specific anti-human leukocyte antigen (HLA) antibodies are not associated with poor outcome in hematopoietic stem cell transplant recipients.. Human Immunology, 81 (8), 407-412. PMID: 32471661 DOI: 10.1016/j.humimm.2020.05.006

Hashmi, S., Oliva J. L.*, Liesveld, J. L., Phillips, G. L. 2nd, Milner, L., Becker, M. W. (*Contributions. SH and JLO contributed equally to all sections of the manuscript) (2013). The hematopoietic cell transplantation specific comorbidity index and survival after extracorporeal photopheresis, pentostatin, and reduced dose total body irradiation conditioning prior to allogeneic stem cell transplantation. Leukemia Research, 37 (9), 1052-6. PMID: 23830733 DOI: 10.1016/j.leukres.2013.06.013

Keller, S. F., Kelly, J. L,, Sensenig, E., Andreozzi, J., Oliva, J., Rich, L., Constine, L., Becker. M., Phillips, G., Liesveld, J., Fisher, R. I., Bernstein, S.H., Friedberg, J. W. (2011). Late Relapses Following High-Dose Autologous Stem Cell Transplantation (HD-ASCT) for Hodgkin Lymphoma (HL) in the ABVD Therapeutic Era. Biology of Blood and Marrow Transplantation, 18 (4), 640-627. PMID: 21871246 PMCID: PMC3269502 DOI: 10.1016/j.bbmt.2011.08.012
Scroll to top of page